切换至 "中华医学电子期刊资源库"

中华神经创伤外科电子杂志 ›› 2023, Vol. 09 ›› Issue (01) : 54 -57. doi: 10.3877/cma.j.issn.2095-9141.2023.01.011

综述

神经内镜治疗慢性硬膜下血肿的研究进展
刘俊1, 陈超1, 罗赤星1, 周波1, 王少波1, 全中平1, 张铭1,()   
  1. 1. 448000 湖北荆门,荆门市第二人民医院神经外科
  • 收稿日期:2021-06-14 出版日期:2023-02-15
  • 通信作者: 张铭

Research progress of neuroendoscopic treatment of chronic subdural hematoma

Jun Liu1, Chao Chen1, Chixing Luo1, Bo Zhou1, Shaobo Wang1, Zhongping Quan1, Ming Zhang1,()   

  1. 1. Department of Neurosurgery, The Second People's Hospital of Jingmen, Jingmen 448000, China
  • Received:2021-06-14 Published:2023-02-15
  • Corresponding author: Ming Zhang
  • Supported by:
    Jingmen Scientific Research Program Project(2022YFYB025)
引用本文:

刘俊, 陈超, 罗赤星, 周波, 王少波, 全中平, 张铭. 神经内镜治疗慢性硬膜下血肿的研究进展[J]. 中华神经创伤外科电子杂志, 2023, 09(01): 54-57.

Jun Liu, Chao Chen, Chixing Luo, Bo Zhou, Shaobo Wang, Zhongping Quan, Ming Zhang. Research progress of neuroendoscopic treatment of chronic subdural hematoma[J]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2023, 09(01): 54-57.

慢性硬膜下血肿(CSDH)是好发于老年人的中枢神经系统疾病,传统的外科治疗方法为钻孔引流术,但部分患者血肿清除不彻底、术后复发率高,对于机化的血肿甚至需行骨瓣开颅手术。近年来研究发现,应用神经内镜的可视化特征能显著提高血肿清除率,降低术后并发症和复发率。本文就神经内镜治疗CSDH的最新研究进展作一综述。

Chronic subdural hematoma (CSDH) is a central nervous system disease that often occurs in the elderly. The traditional surgical treatment is burr hole drainage. However, the hematoma was not completely removed in some cases with high post-operative recurrence rates. For organized hematomas even craniotomy is required. In recent years, studies have found that the application of visualization features of neuroendoscopy can significantly improve the rate of hematoma clearance, and reduce the rate of postoperative complications and recurrence. This article reviews the recent progress of neuroendoscopic therapy for CSDH.

[1]
Motiei-Langroudi R, Stippler M, Shi S, et al. Factors predicting reoperation of chronic subdural hematoma following primary surgical evacuation[J]. J Neurosurg, 2018, 129(5): 1143-1150. DOI: 10.3171/2017.6.JNS17130.
[2]
Chen S, Peng H, Shao X, et al. Prediction of risk factors for the evolution of traumatic subdural effusion into chronic subdural hematoma[J]. Neuropsychiatr Dis Treat, 2020, 16: 943-948. DOI: 10.2147/NDT.S245857.
[3]
Mersha A, Abat S, Temesgen T, et al. Outcome of chronic subdural hematoma treated with single burr hole under local anesthesia[J]. Ethiop J Health Sci, 2020, 30(1): 101-106. DOI: 10.4314/ejhs.v30i1.13.
[4]
苏高健,黄贤键.慢性硬膜下血肿的研究进展[J].中华神经创伤外科电子杂志, 2021, 7(5): 310-313. DOI: 10.3877/cma.j.issn.2095-9141.2021.05.012.
[5]
Du B, Xu J, Hu J, et al. A clinical study of the intra-neuroendoscopic technique for the treatment of subacute-chronic and chronic septal subdural hematoma[J]. Front Neurol, 2019, 10: 1408. DOI: 10.3389/fneur.2019.01408.
[6]
Yadav YR, Ratre S, Parihar V, et al. Endoscopic management of chronic subdural hematoma[J]. J Neurol Surg A Cent Eur Neurosurg, 2020, 81(4): 330-341. DOI: 10.1055/s-0039-1698388.
[7]
王超斌,胡钧涛.慢性硬膜下血肿发病机制研究进展[J].中国神经精神疾病杂志, 2021, 47(10): 628-632. DOI: 10.3969/j.issn.1002-0152.2021.10.012.
[8]
Hamou HA, Clusmann H, Schulz JB, et al. Chronic subdural hematoma[J]. Dtsch Arztebl Int, 2022, 119(12): 208-213. DOI: 10.3238/arztebl.m2022.0144.
[9]
Song P, Li Z, Ke Y, et al. A novel imaging classification system for the neuroendoscopic treatment of chronic subdural hematoma[J]. Am J Transl Res, 2021, 13(11): 12235-12248.
[10]
Ironside N, Nguyen C, Do Q, et al. Middle meningeal artery embolization for chronic subdural hematoma: a systematic review and meta-analysis[J]. J Neurointerv Surg, 2021, 13(10): 951-957. DOI: 10.1136/neurintsurg-2021-017352.
[11]
Ichimura S, Takahara K, Nakaya M, et al. Neuroendoscopic technique for recurrent chronic subdural hematoma with small craniotomy[J]. Turk Neurosurg, 2020, 30(5): 701-706. DOI: 10.5137/1019-5149.JTN.27918-19.4.
[12]
Májovský M, Masopust V, Netuka D, et al. Flexible endoscope-assisted evacuation of chronic subdural hematomas. Acta Neurochir (Wien), 2016, 158(10): 1987-1992. DOI: 10.1007/s00701-016-2902-5.
[13]
Rodziewicz GS, Chuang WC. Endoscopic removal of organized chronic subdural hematoma[J]. Surg Neurol, 1995, 43(6): 569-572, discussion572-573. DOI: 10.1016/0090-3019(95)00005-4.
[14]
Yadav YR, Ratre S, Parihar V, et al. Endoscopic management of chronic subdural hematoma[J]. J Neurol Surg A Cent Eur Neurosurg, 2020, 81(4): 330-341. DOI: 10.1055/s-0039-1698388.
[15]
关峰,彭伟澄,黄辉,等.应用软性神经内镜技术治疗慢性硬膜下血肿的疗效分析[J].中华医学杂志, 2019, 99(9): 695-699. DOI: 10.3760/cma.j.issn.0376-2491.2019.09.012.
[16]
Balevi M. Organized chronic subdural hematomas treated by large craniotomy with extended membranectomy as the initial treatment[J]. Asian J Neurosurg, 2017, 12(4): 598-604. DOI: 10.4103/ajns.AJNS_8_15.
[17]
Ishikawa T, Endo K, Endo Y, et al. Neuro-endoscopic surgery for multi-lobular chronic subdural hematoma[J]. No Shinkei Geka, 2017, 45(8): 667-675. DOI: 10.11477/mf.1436203572.
[18]
Fujimoto T, Morofuji Y, Takahira R, et al. Surgery for a refractory chronic subdural hematoma using an exoscope: a technical case report[J]. No Shinkei Geka, 2019, 47(4): 429-434. DOI: 10.11477/mf.1436203956.
[19]
Kawasaki T, Kurosaki Y, Fukuda H, et al. Flexible endoscopically assisted evacuation of acute and subacute subdural hematoma through a small craniotomy: preliminary results[J]. Acta Neurochir (Wien), 2018, 160(2): 241-248. DOI: 10.1007/s00701-017-3399-2.
[20]
Mahmood SD, Waqas M, Baig MZ, et al. Mini-craniotomy under local anesthesia for chronic subdural hematoma: an effective choice for elderly patients and for patients in a resource-strained environment[J]. World Neurosurg, 2017, 106: 676-679. DOI: 10.1016/j.wneu.2017.07.057.
[21]
Sahyouni R, Mahboubi H, Tran P, et al. Membranectomy in chronic subdural hematoma: meta-analysis[J]. World Neurosurg, 2017, 104: 418-429. DOI: 10.1016/j.wneu.2017.05.030.
[22]
Lee JY, Ebel H, Ernestus RI, et al. Various surgical treatments of chronic subdural hematoma and outcome in 172 patients: is membranectomy necessary?[J]. Surg Neurol, 2004, 61(6): 523-527, discussion527-528. DOI: 10.1016/j.surneu.2003.10.026.
[23]
Guo S, Gao W, Cheng W, et al. Endoscope-assisted surgery vs. Burr-hole craniostomy for the treatment of chronic subdural hematoma: a systemic review and meta-analysis[J]. Front Neurol, 2020, 11: 540911. DOI: 10.3389/fneur.2020.540911.
[24]
Zhang J, Chen J. The therapeutic effects of craniotomy versus endoscopic-assisted trepanation drainage for isolated chronic subdural haematoma (ICSH): A single-centre long-term retrospective comparison study. Brain Res Bull, 2020, 161: 94-97. DOI: 10.1016/j.brainresbull.2020.04.014.
[25]
Ichimura S, Takahara K, Nakaya M, et al. Neuroendoscopic technique for recurrent chronic subdural hematoma with small craniotomy[J]. Turk Neurosurg, 2020, 30(5): 701-706. DOI: 10.5137/1019-5149.JTN.27918-19.4.
[26]
Kramer A, Degenhartt X, Gutenberg A, et al. Risk factors for postoperative seizures in patients with chronic subdural haematomas[J]. Neurosurg Rev, 2022, 45(5): 3291-3298. DOI: 10.1007/s10143-022-01858-5.
[27]
Chavakula V, Yan SC, Huang KT, et al. Subdural pneumocephalus aspiration reduces recurrence of chronic subdural hematoma[J]. Oper Neurosurg (Hagerstown), 2020, 18(4): 391-397. DOI: 10.1093/ons/opz193.
[28]
You CG, Zheng XS. Postoperative pneumocephalus increases the recurrence rate of chronic subdural hematoma[J]. Clin Neurol Neurosurg, 2018, 166: 56-60. DOI: 10.1016/j.clineuro.2018.01.029.
[29]
Stanišic M, Pripp AH. A reliable grading system for prediction of chronic subdural hematoma recurrence requiring reoperation after initial burr-hole surgery[J]. Neurosurgery, 2017, 81(5): 752-760. DOI: 10.1093/neuros/nyx090.
[30]
Liu LX, Cao XD, Ren YM, et al. Risk factors for recurrence of chronic subdural hematoma: a single center experience[J]. World Neurosurg, 2019, 132: e506-e513. DOI: 10.1016/j.wneu.2019.08.089.
[31]
严超,杨明飞.慢性硬膜下血肿术后复发的研究进展[J].中华神经外科杂志, 2019, 35(3): 318-321. DOI: 10.3760/cma.j.issn.1001-2346.2019.03.020.
[32]
Hammer A, Tregubow A, Kerry G, et al. Predictors for recurrence of chronic subdural hematoma[J]. Turk Neurosurg, 2017, 27(5): 756-762. DOI: 10.5137/1019-5149.JTN.17347-16.1.
[33]
Poon MTC, Al-Shahi Salman R. Association between antithrombotic drug use before chronic subdural haematoma and outcome after drainage: a systematic review and meta-analysis[J]. Neurosurg Rev, 2018, 41(2): 439-445. DOI: 10.1007/s10143-017-0860-x.
[34]
Wang Y, Zhou J, Fan C, et al. Influence of antithrombotic agents on the recurrence of chronic subdural hematomas and the quest about the recommencement of antithrombotic agents: a meta-analysis[J]. J Clin Neurosci, 2017, 38: 79-83. DOI: 10.1016/j.jocn.2016.12.001.
[35]
曹德茂,武永康,王友伟,等.微创穿刺联合口服阿托伐他汀治疗慢性硬膜下血肿的疗效分析[J].中华神经创伤外科电子杂志, 2016, 2(2): 83-85. DOI: 10.3877/cma.j.issn.2095-9141.2016.02.005.
[36]
Ridwan S, Bohrer AM, Grote A, et al. Surgical treatment of chronic subdural hematoma: predicting recurrence and cure[J]. World Neurosurg, 2019, 128: e1010-e1023. DOI: 10.1016/j.wneu.2019.05.063.
[37]
Wakuta N, Abe H, Fukuda K, et al. Feasibility and safety of endoscopic procedure in burr-hole surgery for chronic subdural hematoma in patients of very advanced age[J]. World Neurosurg, 2020, 134: e1037-e1046. DOI: 10.1016/j.wneu.2019.11.080.
[38]
Qiu S, Zhuo W, Sun C, et al. Effects of atorvastatin on chronic subdural hematoma: a systematic review[J]. Medicine (Baltimore), 2017, 96(26): e7290. DOI: 10.1097/MD.0000000000007290.
[39]
Yan K, Gao H, Zhou X, et al. A retrospective analysis of postoperative recurrence of septated chronic subdural haematoma: endoscopic surgery versus burr hole craniotomy[J]. Neurol Res, 2017, 39(9): 803-812. DOI: 10.1080/01616412.2017.1321709.
[40]
吴江,卜计源,孙亮,等.神经内镜联合显微镜的双镜技术在松果体区脑膜瘤显微手术中的应用[J].中华医学杂志, 2022, 102(11): 821-824. DOI: 10.3760/cma.j.cn12137-20210719-01605.
[1] 崔占斌, 乔军利, 张丽丽, 韩明强. 尿碘水平与甲状腺乳头状癌患者术后复发危险度分层的相关性[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 615-618.
[2] 陈垚, 徐伯群, 高志慧. 改良式中间上入路根治术治疗甲状腺癌的有效性安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 619-622.
[3] 阿冲罗布, 陈颖, 谢德坤. 腹腔镜外囊完整剥离术治疗肝包虫病效果及对患者肝功能、预后的影响[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 666-669.
[4] 郑泽坤, 刘卓恒, 邹浩, 胡会元, 李妲, 吴巍. 扩大根治性手术切除复发性巨大腹膜后去分化脂肪肉瘤1例[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 588-590.
[5] 贾洪涛, 倪庆强, 于泽涛, 卢俊, 常宏. 肝癌自发性破裂出血的治疗及预后研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(04): 408-412.
[6] 中国器官移植发展基金会器官移植受者健康管理专家委员会, 中国医师协会器官移植医师分会, 中华医学会器官移植学分会, 国家肝脏移植质控中心. 肝移植受者雷帕霉素靶蛋白抑制剂临床应用中国专家共识(2023版)[J]. 中华移植杂志(电子版), 2023, 17(04): 193-204.
[7] 罗辉, 熊珍珍, 黄令杰, 林山, 李金雨. 盆腔淋巴结大小对膀胱癌复发的影响[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 495-499.
[8] 邢晓伟, 刘雨辰, 赵冰, 王明刚. 基于术前腹部CT的卷积神经网络对腹壁切口疝术后复发预测价值[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 677-681.
[9] 姜明, 罗锐, 龙成超. 闭孔疝的诊断与治疗:10年73例患者诊疗经验总结[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 706-710.
[10] 蒋正东, 李徐奇, 王曙逢, 魏光兵. 复发性腹股沟疝的腹腔镜手术策略及疗效观察[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(05): 539-543.
[11] 张文华, 陶焠, 胡添松. 不同部位外生型肝癌临床病理特点及其对术后肝内复发和预后影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 651-655.
[12] 叶文涛, 吴忠均, 廖锐. 癌旁组织ALOX15表达与肝癌根治性切除术后预后的关系[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 708-712.
[13] 王晓东, 汪恺, 葛昭, 丁忠祥, 徐骁. 计算机视觉技术在肝癌肝移植疗效提升中的研究进展[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 361-366.
[14] 张政赢, 鞠阳, 刘晓宁. 二甲双胍对2型糖尿病患者大肠腺瘤术后复发的影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 485-488.
[15] 符梅沙, 周玉华, 李慧, 薛春颜. 淋巴细胞免疫治疗对复发性流产患者外周血T淋巴细胞亚群分布与PD1/PD-L1表达的影响及意义[J]. 中华临床医师杂志(电子版), 2023, 17(06): 726-730.
阅读次数
全文


摘要